GMO is a global investment management firm committed to providing sophisticated clients with superior asset management solutions and services. We offer a broad range of investment products, including equity and fixed income strategies across global developed and emerging markets, as well as absolute return strategies. Our client base includes endowments, pension funds, public funds, foundations and cultural institutions.
GMO is a private partnership that employs more than 550 people worldwide. Investment management is our only business. As of September 30, 2013, we managed $112 billion in client assets, $55 billion of which was in asset allocation strategies.
Our global offices include the firm's headquarters in Boston and offices in San Francisco, London, Amsterdam, Zurich, Singapore, and Sydney. For more information on GMO, please see About GMO.
To read GMO's 3Q 2013 Letter, which contains Ben Inker's "Breaking News! U.S. Equity Market Overvalued!" and Jeremy Grantham's "Ignoble Prizes and Appointments," please click the blue highlighted link.
(To open file, please ensure you have the most recent version of Acrobat Reader installed.)
Other recent commentary available to the public can be found by clicking on the links below: